Abivax - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAbivax

Abivax(ABVX)

Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

type 1 diabetes mellitus

,

,

,

,

type 2 diabetes mellitus

,

,

,

,

movement disorders

,

central nervous system diseases

,

,

neurodegenerative diseases

,

glucose metabolism disorders

,

metabolic diseases

,

endocrine system diseases

,

drug-induced akathisia

,

nervous system diseases

,

chronic hepatitis

,

parkinsonian disorders

,

drug-induced dyskinesia

,

postoperative pain

,

,

,

postherpetic neuralgia

,

liver cirrhosis

,

,

,

castration-resistant prostatic neoplasms

,

non-small-cell lung carcinoma

,

,

alzheimer disease

,

,

thyroid neoplasms

,

thyroid diseases

,

parkinson disease

,

diabetes mellitus

,

chronic hepatitis c

,

,

acquired immunodeficiency syndrome

,

,

immunologic deficiency syndromes

,

small cell lung carcinoma

,

,

coronary artery disease

,

myocardial ischemia

,

,

atherosclerosis

,

rheumatoid arthritis

,

,

neuromuscular blockade

,

prostatic neoplasms

,

,

,

chronic renal insufficiency

,

acute coronary syndrome

,

kidney diseases

,

,

,

,

uterine prolapse

,

intestinal obstruction

,

,

spinal diseases

,

delayed emergence from anesthesia

,

,

,

muscle relaxation

,

,

,

,

urinary retention

,

,

female infertility

,

uterine diseases

,

postoperative complications

,

,

wound infection

,

surgical wound infection

healthy volunteers/patients

,

,

,

,

rheumatoid arthritis

,

,

,

acquired immunodeficiency syndrome

,

ulcerative colitis

,

,

,

respiratory insufficiency

,

renal cell carcinoma

,

,

uterine cervical neoplasms

,

,

chronic hepatitis d

,

,

rheumatoid arthritis

,

,

,

,

chronic hepatitis c

,

chronic hepatitis

healthy volunteers/patients

,

pancreatic neoplasms

,

brain neoplasms

,

,

pharyngeal neoplasms

,

tonsillar neoplasms

,

,

,

head and neck neoplasms

,

colorectal neoplasms

,

rectal neoplasms

,

,

renal cell carcinoma

,

,

myelodysplastic syndromes

,

,

,

retinal diseases

,

diabetic retinopathy

,

,

,

colonic neoplasms

,

squamous cell carcinoma

,

kidney neoplasms

,

systemic scleroderma

,

,

interstitial lung diseases

,

localized scleroderma

,

diffuse scleroderma

,

,

hemangiosarcoma

,

hereditary sensory and autonomic neuropathies

,

breast neoplasms

,

,

non-small-cell lung carcinoma

,

,

lupus nephritis

,

systemic lupus erythematosus

,

,

chronic urticaria

,

triple negative breast neoplasms

,

ovarian neoplasms

,

fallopian tube neoplasms

,

non-hodgkin lymphoma

,

diabetes mellitus

,

vision disorders

,

retinal vein occlusion

,

,

central venous catheters

,

stomach neoplasms

,

,

ovarian epithelial carcinoma

,

neoplasm metastasis

,

rheumatoid arthritis

,

,

macular degeneration

,

follicular lymphoma

,

,

,

intracranial hemorrhages

,

cerebral hemorrhage

,

cerebral intraventricular hemorrhage

,

b-cell lymphoma

,

,

hepatocellular carcinoma

,

liver neoplasms

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use